Vox Markets Logo

AMRYT Listed on NASDAQ & CEO Rings the CLOSING BELL

14:49, 8th July 2020
Vox Markets
RNS Newswire
TwitterFacebookLinkedIn

Amryt Pharma  FOLLOW (Nasdaq: AMYT, AIM: AMYT; Euronext Growth: AYP) announces that its American Depositary Shares (“ADSs”) are now trading on the Nasdaq Global Select Market (“Nasdaq”) under the symbol AMYT and Dr Joe Wiley will also ring the Nasdaq closing bell (virtually) later today.

The Company has not issued any new securities in connection with this filing. The Ordinary Shares will continue to trade on the AIM market of the London Stock Exchange (“AIM”) and the Euronext Growth Market in Dublin (“Euronext”).

The Company also announces today that Mr. Ray Stafford (Company Chairman), Dr Joe Wiley (Company CEO) and Mr. Rory Nealon (Company CFO/COO) will be converting their Ordinary Shares into ADSs in the first month post listing on Nasdaq.

Each ADS represents five of the Company’s ordinary shares (“Ordinary Shares”).

Citibank can accommodate all shareholders should they wish to convert their Ordinary Shares into ADSs. Should shareholders have any questions in relation to the mechanics of converting their Ordinary Shares into ADSs, they are advised to contact their broker.

Joe Wiley, CEO of Amryt, commented: “Listing on Nasdaq is a very important milestone for Amryt and will provide us with the opportunity to improve underlying liquidity in our shares, target a wider investor audience and increase our analyst coverage. With nearly 70% of our shareholders based in North America, listing on Nasdaq is an important part of our shareholder engagement and development plans. Furthermore, we believe our Nasdaq listing will significantly assist our efforts to drive value for all our stakeholders.

Amryt’s CEO, Dr Joe Wiley, will also virtually ring the Nasdaq closing bell today. The Amryt virtual closing bell ceremony will be broadcast live starting at 15:45 EDT (20:45 BST) from the Nasdaq MarketSite Tower in New York City. Watch below

“Ringing the closing bell on Nasdaq is a great honour for all the Amryt team and we are very much looking forward to participating later today.” Added Dr Wiley.

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
Watchlist